Prognia
Drug Database
🇪🇺EU · EMAWithdrawn

Aftovaxpur DOE(Maximum three of the following purified, inactivated foot-and-mouth disease virus strains: O1 Manisa ≥ 6 PD50*; O1 BFS ≥ 6 PD50*; O Taiwan 3/97 ≥ 6 PD50*; A22 Iraq ≥ 6 PD50*; A24 Cruzeiro ≥ 6 PD50*; A Turkey 14/98 ≥ 6 PD50*; Asia 1 Shamir ≥ 6 PD50*; SAT2 Saudi Arabia ≥ 6 PD50*; * PD50 – 50% protective dose in cattle as described in Ph. Eur. monograph 0063.)

Marketing Authorisation Holder: Boehringer Ingelheim Vetmedica GmbH

EMA Authorisation: 15/07/2013

INN: inactivated vaccine against foot-and-mouth disease

Indication

Active immunisation of cattle, sheep and pigs from 2 weeks of age against foot-and-mouth disease to reduce clinical signs.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Aftovaxpur DOE — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Ask about Aftovaxpur DOECreate Free Account

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.